Clinical trial · Interventional
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
Prostate Cancer Screening and Dietary HA Exposure in African-Americans: Phase II
NCT00354497CI-TRIAL-00012185unknownPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat. The amount of heterocyclic amines in the diet may affect prostate cancer screening results and the risk of prostate cancer. PURPOSE: This phase II trial is studying prostate cancer screening and dietary heterocyclic amines in African American men.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| evaluation of cancer risk factors | Procedure | — | UNRESOLVED |
| mutation carrier screening | Procedure | — | UNRESOLVED |
| physiologic testing | Other | — | UNRESOLVED |
| study of high risk factors | Procedure | — | UNRESOLVED |
| study of socioeconomic and demographic variables | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Dietary heterocyclic amine (HA) exposure in African American men
- measure
- Correlation of HA exposure with prostate cancer screening results
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 50 Years
- Maximum age
- 70 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * African American male * No previous diagnosis of prostate cancer * Desires prostate cancer screening as a routine preventative medical service PATIENT CHARACTERISTICS: * Lives in or near Oakland, California * Speaks English * No medical or other disability (e.g., blindness, psychological dysfunction, or amputation) that would preclude study participation PRIOR CONCURRENT THERAPY: * Not specified
References
Publications (0)
Data not yet available
No reference posted for this study.